1 results match your criteria: "University of Texas Health Science Center at San Antoni(UTHSCSA)[Affiliation]"
Evaluation Of Two Thromboembolism (TE) Risk Methods And Oral Anticoagulation Use Among Cardiac Device Patients With Atrial Tachyarrhythmias (AT).
J Atr Fibrillation
December 2014
Assistant Professor of Medicine and Director of Clinical Cardiac Electrophysiology, University of Texas Health Science Center at San Antoni(UTHSCSA), San Antonio, TX 78229.
Background: In the implantable cardiac device (CD) population, not only can clinically silent atrial tachyarrythmias (AT) be detected, but an associated AT burden can be documented. There are two methods of determining stroke risk: CHADS and CHADS-VASc. Recommendations for initiating anticoagulation based on stroke risk profiles and/or AT burden remain unclear for device-detected AT.
View Article and Find Full Text PDF